Cabergoline - CISMeF

Preferred Label : Cabergoline;

MeSH definition : An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.;

MeSH synonym : 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea;

MeSH hyponym : FCE-21336; 1-Ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate;

MeSH CAS label : Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-;

MeSH Related Number : 477M7SA9N9; 81409-90-7 (Cabergoline);

Wikipedia link : https://en.wikipedia.org/wiki/Cabergoline;

UNII : LL60K9J05T;

Details

Origin ID

D000077465;

UMLS CUI

C0107994;

ATC code(s)
- cabergoline [ATC Code]
- cabergoline [ATC Code]
ATC code(s)
- cabergoline [ATC Code]
- cabergoline [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Cabergoline adverse reaction (disorder) [SNOMED CT concept]
- cabergoline [Substance BNPC]
Pharmacological action(s)
- antiparkinson agents [MeSH Descriptor]
- dopamine agonists [MeSH Descriptor]
Record concept(s)
- Cabaseril [MeSH concept]
- Dostinex [MeSH concept]
- FCE 21336 [MeSH concept]
- cabaser [MeSH concept]
- cabergoline [MeSH concept]
- cabergoline diphosphate [MeSH concept]
- galastop [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Validated automatic mappings to BTNT
- cabergoline [ATC Code]
- cabergoline [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients